ABTI - ALTEROLA BIOTECH INC.

0.0017
-0.001   -29.412%

Share volume: 5,000
Last Updated: 04-03-2025
Pharmaceutical Products/Medicinal Chemicals: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
-0.23%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
54%
Profitability 60%
Dept financing 43%
Liquidity 1%
Performance 65%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-52.78%
3 Months
-48.48%
6 Months
-48.48%
1 Year
-48.48%
2 Year
-48.48%
Key data
Stock price
$0.00
P/E Ratio 
0.00
DAY RANGE
$0.00 - $0.00
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.01
52 WEEK CHANGE
-$48.48
MARKET CAP 
5.838 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$133,744
AVERAGE 30 VOLUME 
$133,744
Company detail
CEO: Timothy Paul Rogers
Region: US
Website: alterola-abti.com
Employees: 0
IPO year: 2019
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Alterola Biotech, Inc. engages in the development of cannabinoid and cannabinoid-like molecules. The company is based in Birkenhead, the United Kingdom.

Recent news
loading